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Abstract
The Niemann-Pick type C1 (NPC1) disease is a neurodegenerative lysosomal storage disorder due to mutations in the NPC1
gene, encoding a transmembrane protein related to the Sonic hedgehog (Shh) receptor, Patched, and involved in intracellular
trafficking of cholesterol. We have recently found that the proliferation of cerebellar granule neuron precursors is signifi-
cantly reduced in Npc1/ mice due to the downregulation of Shh expression. This finding prompted us to analyze the forma-
tion of the primary cilium, a non-motile organelle that is specialized for Shh signal transduction and responsible, when de-
fective, for several human genetic disorders. In this study, we show that the expression and subcellular localization of Shh
effectors and ciliary proteins are severely disturbed in Npc1-deficient mice. The dysregulation of Shh signaling is associated
with a shortening of the primary cilium length and with a reduction of the fraction of ciliated cells in Npc1-deficient mouse
brains and the human fibroblasts of NPC1 patients. These defects are prevented by treatment with 2-hydroxypropyl-b-cyclo-
dextrin, a promising therapy currently under clinical investigation. Our findings indicate that defective Shh signaling is re-
sponsible for abnormal morphogenesis of the cerebellum of Npc1-deficient mice and show, for the first time, that the forma-
tion of the primary cilium is altered in NPC1 disease.
Introduction
The Niemann-Pick type C1 (NPC1) disease is an autosomal re-
cessive disorder of cholesterol storage caused by the mutation
of either the NPC1 or NPC2 genes, encoding for proteins that co-
operatively mediate the egress of cholesterol from endosomes/
lysosomes (1–4). The deficiency of either protein leads to the ac-
cumulation of endocytosed, unesterified cholesterol and of sev-
eral sphingolipids within the late endosomal/lysosomal (LE/Ly)
compartment (2,3), decreasing the metabolic active pool of
unesterified cholesterol in the cytosol. The disease is considered
a disease of neurodegeneration (5,6). In fact it has been called
‘juvenile Alzheimer’s’ (7) because of its shared characteristics,
including abnormal cholesterol metabolism, neurofibrillary tan-
gles, increased levels of amyloid beta (8) and TDP-43 proteinop-
athy (9).
Most of NPC1 defects are prevented by early treatment with
2-hydroxypropyl-b-cyclodextrin (CD). It was clear from the first
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report, using somatic delivery of cyclodextrins in a mouse
model of NPC1 that highly significant delays in the onset of
symptoms occurred, even though the blood brain barrier (BBB)
was found to block the drug (10). When somatic treatment was
initiated at postnatal day 7, when the BBB is not fully formed in
the mouse, and higher doses were used, the results were more
dramatic (11). The effects are well seen in the developing cere-
bellum where nearly complete correction of the developmental
defects occurs (12,13).
The disease is also a disorder of development with altered
morphogenesis. This is particularly true of the cerebellum, in
which several anomalies of glial cell differentiation and de-
rangement of synaptic input to Purkinje cells (PCs) are respon-
sible for a delay in the acquisition of complex motor skills in
pre-puberal Npc1-deficient mice, and may contribute to the
later PC degeneration (13). Moreover, significantly reduced Sonic
hedgehog (Shh) mRNA levels at the time of terminal granule cell
precursor divisions cause a reduction in cerebellar lobule size at
the end of cerebellar development (12).
There is abundant evidence for the role that Shh signaling
plays in cerebellum development (14–16). In vertebrates, Shh
mostly acts at the level of primary cilium, a microtubule-based
plasma membrane protrusion. Defects in the formation and
structure of primary cilium are associated with syndromes with
altered cerebellar morphogenesis (17). Patched (Ptch), the Shh
receptor, localizes on the plasma membrane of the cilium base
and axoneme and prevents the activation of Smoothened
(Smo), retaining it within intracellular vesicles. Once bound to
Shh, Ptch is removed from the cilia membrane and the inhib-
ition of Smo is relieved, allowing Smo to localize at the cilium
membrane, while the Shh-Ptch complex is internalized and
degraded by lysosomes (reviewed in Ref. 18). The mechanism
responsible for the relief of Smo inhibition in consequence of
Shh binding to Ptch still needs clarification, although evidence
indicates that it depends on the activity of small molecules of
lipid origin, the availability of which is controlled by Ptch
(19,20). A key role in the control of Shh signaling is played by the
kinesin Kif7, an anterograde motor protein that was recently
shown to localize at the cilium tip, where it controls cilium
length and structure (21). Kif7 mediates the activation and
translocation of Gli (glioma-associated) proteins to the tip of the
cilium by physically interacting with Gli transcription factors
and influencing their processing (22). In vertebrates, the zinc-
finger transcription factors Gli1, Gli2 and Gli3 are the effectors
of Shh signaling (23), controlling the expression of genes
involved in cell proliferation and cell cycle progression (24). Gli1
and Gli2 usually act as transcriptional activators and full-length
or a truncated form of Gli3, as transcriptional activator or re-
pressor, respectively (25–27).
A possible effect of NPC1 deficiency on Shh signaling was
previously hypothesized in light of the covalent attachment of a
cholesterol moiety to the C-terminus of the proteolytically gen-
erated active Shh fragment (28). The presence in the NPC1 pro-
tein of a sterol-sensing domain with homology to Ptch (29) also
heightened interest in a possible role of Shh signaling in the dis-
ease. Furthermore, it was shown that NPC1 trafficking antagon-
ists are weak Shh inhibitors (30). However, the fact that NPC1
patients and mice do not display severe birth defects, e.g. holo-
prosencephaly, cyclopia and limb deficiencies, typically
observed in Shh knockout mice (31,32) and patients carrying
mutations in the SHH gene (33), suggests that SHH signaling is
not completely deficient in NPC1 disease. Recently, a mouse
model carrying a mutation in the NAD(P) dependent steroid
dehydrogenase-like (Nsdhl) gene, therefore affecting the
cholesterol synthesis pathway, has been exploited to show that
cholesterol has an essential role in Shh signaling also in cere-
bellar granule cell precursors (34). Without cholesterol, there
was a significant decrease in granule cell proliferation, as we
observed in the Npc1/ mice (12), and as might be expected in
NPC1 deficiency where intracellular cholesterol transport is
altered, potentially decreasing cholesterol availability for regu-
latory mechanisms. Among these, the regulation of cell cycle
progression (35) and the Shh signal transduction per se (36) are
likely candidates. In fact, the activity of the two main effectors
of Shh pathway, Ptch and Smo is tightly linked to cholesterol
metabolism. Ptch inhibits the enrichment of Smo at the plasma
membrane by modulating the intracellular concentration of
cholesterol (37). Oxysterols, cholesterol derivatives, promote the
translocation of Smo to the primary cilium (38) and are emerg-
ing as crucial modulators of Smo activity (39,40).
We now present evidence that the expression and subcellu-
lar localization of Shh effectors and ciliary proteins are severely
disturbed in Npc1-deficient mice. We also present evidence of
shortened primary cilia in NPC1 mouse model brains and fibro-
blasts from NPC1 patients, providing further support to the idea
of Shh signaling deficiency in the developing cerebellum of
NPC1 model mice.
Results
Altered expression of Shh downstream effectors
Previous data obtained in our laboratory showed that a signifi-
cant reduction of Shh transcripts correlates with the defective
proliferation of granule neuron precursors in the cerebella of 2-
week-old Npc1-deficient mice, allowing us to trace the onset of
this defect between PN12 and PN14 (12). To better characterize
the likely contribution of anomalous Shh signaling to this de-
fect, we have now determined whether the Npc1-deficiency af-
fects the expression of Shh effectors, including Ptch, Smo, Kif7
and Gli1, Gli2 and Gli3. We analyzed the level of transcripts
mentioned above on PN12 mouse cerebella by real time reverse
transcriptase polymerase chain reaction (RT-PCR), observing
that the deficiency of Npc1 was associated with a severe dysre-
gulation of the expression of all components analyzed. In par-
ticular, the expression levels of Ptch, Smo and Gli3 were
significantly reduced, whereas those of Gli1, Gli2 and Kif7 were
significantly increased (Fig. 1). The administration of CD to
Npc1-deficient mice re-established the expression of all factors
to levels similar to those of wt mice. Moreover, it is worth noting
that the dysregulation of Shh signal transduction largely antici-
pated the proliferation defect of GN precursors, as indicated
by the finding that abnormal transcript levels were
already observed in Npc1-deficient cerebella of PN7 mice
(Supplementary Material, Fig. S1).
To better characterize Ptch and Smo expression, we also per-
formed western blot analyses in Npc1-deficient mice of increas-
ing ages (PN12, PN18 and PN45). A comparison of Ptch and Smo
proteins between cerebella of wt and untreated or CD-treated
Npc1-deficient mice is shown in Figure 2. This analysis con-
firmed the significant reduction in Ptch and Smo proteins of
Npc1-deficient mice, already observed in transcript levels, ex-
cept that a significant reduction of Ptch protein appeared from
PN18 onward, but not at PN12. The administration of CD re-
established in the Npc1-deficient mice, protein levels similar to
those of wt ones.
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The subcellular localization of Ptch and Smo is severely
impaired in Npc1-deficient cerebella
A recent study reported that Ptch and Smo localize at the level
of the growth cone and within processes of cerebellar neurons
during postnatal development, whereas in PCs, granule neurons
and interneurons of the adult cerebellum they predominantly
localize at the postsynaptic site (41). We investigated this issue
by immuno-electron microscopy, observing a Ptch and Smo
subcellular localization in wt mouse cerebella that is in agree-
ment with previous observations (41). Protein abundance and
subcellular localization, however, were profoundly altered in
Npc1-deficient mice (Fig. 3). Specifically, in untreated or CD-
treated PN18 wt mice, Ptch (Fig. 3C and D) and Smo (Fig. 3H and
K) immunopositive vesicles were associated with postsynaptic
densities within dendritic spines of PCs. Sometimes, post-
synaptic densities themselves appeared positive (Fig. 3C and D,
Ptch; 3K, Smo). Both factors, however, were frequently found in
vesicular elements within small and large dendritic spines
(Fig. 3E, Ptch; 3J and L, Smo), as also associated with their
plasma membrane (Fig. 3F, Ptch; 3J, Smo), independently of the
presence of an established synapse. Moreover, frequent immu-
nopositive membrane pits and vesicles were seen approaching
(or coming from) the spine plasma membranes (Fig. 3B, Ptch; 3L,
Smo). Large immunopositive vesicles were also observed within
the PC soma, often close to the sites of protein synthesis and
maturation (endoplasmic reticulum (rer) and Golgi) (Fig, 3A,
Ptch; 3I, Smo). Less frequently, both Ptch and Smo immunoposi-
tive vesicles were also clustered in pre-synaptic boutons that
granule cells form on PC dendrites, distributed both among syn-
aptic vesicles and very close to the active sites (Fig. 3A and G,
Ptch). The presence of Ptch and Smo immunopositive vesicles
recycled from the plasma membrane and clustered in multive-
sicular bodies (mvb) (degradation sites) was the most striking
feature characterizing PCs of Npc1-deficient mice (Fig. 3N, Ptch;
3U, Smo). Ptch and Smo immunopositive small vesicles within
pre-synaptic boutons (Fig. 3P and Q, Ptch; 3W, Smo), PC soma
(Fig. 3M, Ptch) and dendrites (Fig. 3O, Ptch; 3V, Smo) were also
Figure 1. Altered expression of Shh downstream effectors in Npc1/ mice. Transcript levels were determined by semi-quantitative real-time PCR of total RNA of PN12
wt (empty bars), Npc1/ (full bars) and Npc1/ CD (dashed bars) mice. Histograms indicate the mean 6 S.E.M. of values obtained in three independent assays.
Asterisks indicate statistically significant differences (*P < 0.05; **P <0.01; ***P < 0.001).
Figure 2. The expression of Ptch and Smo is downregulated in Npc1-deficient cerebella. Western blot analysis of Ptch and Smo protein expression in the cerebella of
PN12, PN18 and adult wt (empty bars), Npc1/ (full bars) and Npc1/ CD (dashed bars) mice. Histograms indicate the abundance (mean 6 S.E.M.) of each protein
determined by densitometry of protein bands obtained in three independent experiments, taking b-actin as internal reference. Asterisks indicate statistically signifi-
cant differences (*P < 0.05; **P < 0.01; ***P < 0.001).
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Figure 3. The subcellular distribution of Ptch and Smo is severely impaired in PN18 Npc1-deficient mouse cerebellum compared with wt, and recovers after CD treat-
ment. Anti-patched in wt mice without CD treatment (A–D). (A) Two large immunopositive vesicles (arrows) are localized within a pre-synaptic bouton approaching a PC
soma. Within the cell, a large immunopositive vesicle (open block arrow) is associated with a cistern of the rer). (B) Immunopositive plasma membrane pit (arrowhead)
within a dendrite. (C) Immunopositive vesicle (arrow) very close to an immunolabeled post-synaptic density in a dendritic spine. (D) Immunopositivity associated with
a postsynaptic density within a dendritic spine facing a pre-synaptic bouton. Anti-patched in wt mice after CD treatment (E–G). Amount and localization of patched immu-
noreactivity does not vary after CD treatment compared with untreated animals. (E) Immunopositive vesicles (arrows) within a terminal dendrite of a PC. (F) Large clus-
ter of immunoreactivity (arrow) in between two dendritic spines and a synaptic bouton. (G) Immunopositive vesicles (arrow) within a pre-synaptic bouton contacting a
dendritic spine. Anti-smoothened in wt mice without CD treatment (H–J). (H) Large and heavily immunopositive vesicles (arrows) are in the proximity of a post-synaptic spe-
cialization within a PC dendrite, flanked by synaptic boutons; (I) in the cell body of a PC, proximal to the plasma membrane, (J) in a dendritic spine. The plasma mem-
brane of the spine is also decorated by immunoreactivity. Anti-smoothened in wt mice after CD treatment (K and L). Amount and localization of immunoreactivity does not
vary after CD treatment compared with untreated animals. (K) An immunopositive vesicle (arrow) in a dendritic spine is localized in the proximity of a post-synaptic
density, also immunopositive. (L) Immunopositive vesicle (arrow) localized within a dendrite, which in turn bears immunolabeled plasma membrane pits (upper left
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observed. However, the occurrence of immunopositive elem-
ents was dramatically less compared with that observed in wt
mouse specimens, a reduction that was particularly pro-
nounced for Smo. A similar pattern of subcellular distribution of
Ptch and Smo immunopositive elements was also observed in
PN45 wt and Npc1-deficient mice (Supplementary Material, Fig.
S2), with the difference that immunopositivity in adult null
mice was even more scanty than that observed in CD-untreated
PN18 null mice. Moreover, Npc1-null adult mouse cerebella
showed consistent neurodegeneration (Supplementary
Material, Fig. S2). Conversely, PN18 and PN45 Npc1-null mice
that had received the CD treatment recovered Ptch and Smo
immunopositivity, the pattern and intensity of which were
similar to those of age-matched wt mice. This indicates that the
re-wiring of the Shh signal transduction is among the molecular
mechanisms underlining the CD beneficial effect on rescuing
the anomalies of cerebellar morphology (12).
The expression of markers of primary cilium shaft is
significantly reduced in Npc1-deficient mouse cerebella
Abnormal patterns of expression and subcellular localization of
Ptch and Smo indicate that, besides a reduced level of Shh lig-
and availability, Npc1-deficiency leads to a widespread disor-
ganization of the machinery involved in Shh signal reception
and transduction. In light of the finding that molecular compo-
nents of this machinery localize at the primary cilium, we asked
whether defective primary cilia are responsible for abnormal
cerebellum morphogenesis and Shh signaling. To address this
question we analyzed the expression levels of ACIII and c-tubu-
lin, two well-established markers of the cilium shaft and basal
body (42,43), respectively. The comparison of protein extracted
from wt and either untreated or treated Npc1-deficient mice of
increasing ages (PN12, PN18 and PN45) showed a significant re-
duction in both markers at all PN ages, suggesting defective cil-
iogenesis (Fig. 4). To verify this possibility we sought to visualize
primary cilia by immunofluorescence (IF) and/or immunohisto-
chemistry (IHC) on histological sections of wt and Npc1-
deficient mouse cerebella. Unfortunately, this analysis was ex-
tremely challenging due to the tight packaging of the granule
neurons of both the external and internal layers of PN12 and
adult cerebella, although scanty and stubby primary cilia
could be visualized (Supplementary Material, Fig. S3).
Meanwhile, we also noticed that the detection and identifica-
tion of primary cilium at the level of hippocampus was easier
(Supplementary Material, Fig. S4), likely because hippocampal
neurons mostly complete their differentiation prior to birth
(44). Conversely, neurons of the postnatal cerebellum are still
differentiating at PN12 and thus display a highly variable pri-
mary cilium presence, position and length, as differentiating
neurons do (45).
Primary cilia of Npc1-deficient neurons and NPC1
patient fibroblasts display a reduced length
Our analysis of primary cilium morphology in hippocampal sec-
tions showed that adult hippocampal cells of both dentate
gyrus and cornus ammonis had longer cilia as compared with
PN12, in agreement with previous studies (46,47). Based on this
observation, and in light of the similarities between cerebellum
and hippocampus with respect to the expression of Shh signal-
ing components (48), we thought it was reasonable to perform
morphological analyses of cilia on sagittal sections of adult
hippocampus. We therefore analyzed the fraction of ciliated
cells and the length of primary cilia on the hippocampus of
adult wt mice and compared them to those of either untreated
or CD-treated Npc1-deficient mice. Primary cilia were routinely
detected with antibodies directed to ACIII. This analysis showed
that the fraction of hippocampal neurons provided with cilia
was significantly reduced in Npc1-deficient hippocampi com-
pared with the wt ones (Fig. 5A and B). Strikingly, the cilia of
Npc1-deficient neurons also displayed a 25% length reduction
with respect to wt. The treatment with CD led neurons of Npc1-
deficient mice to display a fraction of ciliated cells and cilium
length similar to those of wt mice (Fig. 5B and C), indicating that
defective ciliogenesis was rescued by the CD administration. In
contrast, CD administration had no effect on the neurons of wt
mice (Fig. 5A–C).
Besides neurons, fibroblasts represent a convenient model
system for studying ciliogenesis, as they respond to Shh stimu-
lation, even though they do not release the Shh ligand (49). We
therefore took advantage of NPC1 human fibroblasts to deter-
mine whether the defective ciliogenesis observed in neurons of
Npc1-deficient mice was also a feature of the disease in
humans. To this aim, we first performed co-IF analyses on wt
and NPC1 human fibroblasts of acetylated a-tubulin that binds
microtubules and thus allows the visualization of the primary
cilium axoneme, and c-tubulin, a specific marker of the basal
body. Consistent with our findings in the mouse model, both
the fraction of NPC1 human fibroblasts provided with cilia and
the cilium length was significantly reduced when compared
with fibroblasts from healthy controls (Fig. 6A). In light of these
findings, we next assessed the effect of CD on cilium length in
human fibroblasts. To this end, the culture medium of control
and NPC1 fibroblasts was supplemented with increasing con-
centrations of CD and the cilium length was determined by IF.
arrowheads) and intracellular membrane profiles (open block arrow). Another large immunopositive pit (lower right arrowhead) is observed in the nerve fiber running
close by. Anti-patched in Npc1-deficient mice without CD treatment (M–Q). (M) Large immunopositive vesicles (open arrowheads) are moving from cisterns of the rer to the
Golgi apparatus (g). (N) A cluster of mvb contain immunopositive vesicles (arrows) recycled from the plasma membrane. (O) Very large aggregate of immunoreactivity
localized near to the post-synaptic membrane of a PC dendrite. (P) Immunopositive small vesicles (arrow) tightly juxtapose to the plasma membrane of a synaptic bou-
ton. (Q) Immunopositive vesicle (arrow) within a pre-synaptic bouton. Anti-patched in Npc1-deficient mice after CD treatment (R–T). Amount, intensity, size and localization
of the immunoprecipitates increase after CD treatment compared with untreated animals. (R) Large, single immunopositive vesicles (arrows) travel along adjacent par-
allel fibers (Ax). (S) Large vesicular aggregates of immunoreactivity (arrows) localized in the soma of a PC. (T) Immunoreactivity (arrow) decorates a portion of the
plasma membrane of a dendritic spine and fills an invaginating plasma membrane pit (arrowhead) in the adjacent nerve fiber (f). Anti-smoothened in Npc1-deficient mice
without CD treatment (U–W). (U) Immunopositive (arrow) mvb within a PC soma. Close by, another mvb is immunonegative. (V) Immunopositive vesicles (arrows) within
a dendritic spine. f, nerve fibers. (W) Small immunopositive vesicles (arrow) localized close to the pre-synaptic membrane of a bouton. Anti-smoothened in Npc1-deficient
mice after CD treatment (X–Z). Amount, intensity, size and localization of the immunoprecipitates increase after CD treatment compared with untreated animals. (X) A
large aggregate of immunoreactivity, clustered around a vesicular structure (arrow), is localized within a PC soma. Close by, an immunopositive vesicle (arrowhead) is
associated with the plasma membrane. (Y) Immunopositive vesicles (arrow), clustered in a synaptic bouton, are tightly juxtaposed to the pre-synaptic plasma mem-
brane. (Z) Intense aggregates of immunoreactivity are associated with a post-synaptic density in a dendritic spine. Common abbreviation: d, dendrites; s, dendritic
spines; b, presynaptic boutons. Scale bar: 1 lm.
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The exposure of cells to CD resulted in a significant rescue of
the cilium length of Npc1-deficient fibroblasts, no CD effect
being observed in control fibroblasts (Fig. 6B). In particular, both
CD concentrations caused a significant improvement, which
was more pronounced with the higher concentration.
Discussion
The findings of this study expand the present knowledge of the
molecular and cellular mechanisms that underlie the mild cere-
bellar hypoplasia of Npc1/ mice (12), by demonstrating that
Figure 4. The expression of primary cilium shaft markers is significantly reduced in Npc1-deficient mouse cerebella. Western blot analysis of primary cilium markers,
ACIII and c-tubulin, in cerebella of PN12, PN18 and adult wt (empty bars), Npc1/ (full bars) and Npc1/ CD (dashed bars) mice. Histograms indicate the abundance
(mean 6 S.E.M.) of each protein determined by densitometry of protein bands obtained in three independent experiments, taking b-actin as internal reference.
Asterisks indicate statistically significant differences (*P < 0.05; **P < 0.01).
Figure 5. Primary cilia of Npc1-deficient neurons display a reduced length. (A) Detection of primary cilia of the hippocampus of adult wt and Npc1/ mouse, either un-
treated or CD-treated, by IF with antibodies against ACIII (green). Representative fields of confocal images are shown in the figure. Scale bar: 2.5 lm. Nuclei were stained
with propidium iodide (red). Insets (bottom right) higher magnifications. Scale bar: 5 lm. (B, C) Histograms indicate (mean 6 S.E.M.) the proportion of ciliated cells and
the primary cilium length of adult wt (empty bars) and Npc1/ (full bars) mouse, either untreated (empty dashed bars) or CD-treated (full dashed bars), determined by
examining 800 cells per experimental group. Asterisks indicate statistically significant differences (*P < 0.05, **P < 0.01).
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Shh signal generation and reception at the primary cilium are
negatively affected by Npc1-deficiency. This conclusion is in
agreement with genetic studies in both mouse models and con-
genital human syndromes that have extensively demonstrated
the dependence of normal cerebellar morphogenesis and size
on Shh signaling at the level of primary cilium (15,50). In add-
ition, our results emphasize the influence of cholesterol
metabolism on the Shh pathway, as already suggested by the
finding that the congenital malformations of Smith-Lemli-Opitz
syndrome, which is due to mutations in the gene encoding the
cholesterol biosynthetic enzyme 7-dehydrocholesterol reduc-
tase, are similar to those caused by aberrant Shh signaling (51).
More recently, the ablation of 3b-hydroxysterol dehydrogenase,
an enzyme involved in one of the later steps of cholesterol
Figure 6. Primary cilia of NPC1 patient fibroblasts display a reduced length. (A) Detection of primary cilia of cultured human fibroblasts from healthy control (right) and
NPC1 patients (left), by IF with antibodies against acetylated a-tubulin (green) and c-tubulin (red). Representative fields are shown in the figure. Insets (bottom right),
higher magnifications. Nuclei were stained with DAPI. Scale bar: 20lm (panels) and 5 lm (insets). Histograms indicate (mean 6 S.E.M.) the proportion of ciliated cells
(right) and the primary cilium length (left) of control (empty bars) and NPC1 patients (full bars) (B). Detection of primary cilia of cultured human fibroblasts from healthy
control and NPC1 patients cultured for 24 h in the presence of 400 or 800 lM CD and immunostained with antibodies against acetylated a-tubulin (green).
Representative fields are shown in the figure. Insets (upper right) higher magnifications. Histograms indicate (mean 6 S.E.M.) the proportion of ciliated cells and the
primary cilium length of healthy controls (n ¼ 4) and NPC1 patients (n ¼ 7) determined by examining at least 100 cells per experimental group. Asterisks indicate statis-
tically significant differences (***P < 0.001). Scale bar: 20 lm (panels) and 5 lm (insets).
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biosynthesis, demonstrated the absolute requirement for chol-
esterol biosynthesis in the developing CNS after the complete
formation of the BBB (34). Because Npc1 deficiency severely af-
fects granule cell proliferation and Shh signaling is significantly
down-regulated, it is likely that the developing cerebellum is
very dependent on cholesterol, perhaps attached to Shh (28), as
also suggested by the finding that the deficiency for the essen-
tial embryonic carrier of cholesterol, apolipoprotein B, particu-
larly affects the hindbrain formation (52).
The addition of fatty acids (53) improves Shh hydrophobicity
and localization to lipid rafts which are increased in primary
cilia, since ciliary membranes are unusually enriched in sterols,
glycolipids and sphingolipids (54). However, the finding of a sol-
uble, diffusible and cholesterol-modified form of Shh in condi-
tioned media, a form which had a gradient in the chick limb,
argues against an essential role of the Shh-cholesterol and lipid
raft association for Shh signaling (55), although this notion is
now heavily discounted (56). Another alteration observed in
Niemann-Pick C1 that may be relevant to Shh signaling in pri-
mary cilium is the elevated caveolin-1 level (57), since Ptch as-
sociates with caveolin-1 in lipid rafts (58). An excess of Ptch is
likely to require greater amounts of Shh ligand for inhibition of
the repression it exerts on Smo. Moreover, the fact that Ptch
contains a sterol-sensing domain (29) and is involved in the ef-
flux of cholesterol from the cell (37), likely contributing to the re-
pression of Smo, also argues for a negative effect of cholesterol
dishomeostasis on Shh signaling in NPC1 disease.
Our measurements of mRNA levels of Shh pathway compo-
nents, Ptch and Smo, and downstream effectors Gli1-3, in PN7
and PN12 cerebella, have shown that they are consistently dys-
regulated in Npc1/ mice. While the down-regulation of Ptch
and Smo transcripts is in agreement with the decreased avail-
ability of Shh ligand in Npc1-deficient cerebella (12), the explan-
ation for the changes we observed in the expression levels of
Kif7 and Gli factors is quite puzzling. In particular, instead of an
increase, we would have expected a reduction of Gli1 and Gli2
transcripts, due to their expression being directly regulated by
Shh (49). On the other hand, the decrease of Gli3 mRNA levels in
the cerebellum of Npc1/ mice is consistent with the presence
of a defective Shh signaling leading to abnormal cerebellar mor-
phogenesis. Gli3, one of 3 Gli downstream effectors of Shh, has
both activator and repressor forms. It has been well shown to
play a critical role in Shh signaling in the developing cerebellum
where it coordinates growth and 3D patterning (59). The level of
Gli3R is regulated by Shh to control neural stem cell proliferation
(60). Importantly, as suggested by our data, not only is the cere-
bral cortical size regulated by primary cilia and Gli3 activity (61),
but also the cerebellum. The dysregulation of Gli transcription
factors is possibly linked to a disorganization of the primary cil-
ium tip compartment, as suggested by the abnormal expression
of Kif7 in Npc1/ mice. Kif7, the vertebrate homolog of
Drosophila Costal2, is a kinesin motor protein belonging to the
kinesin-4 family, which regulates the activity of Cubitus interrup-
tus (the Drosophila homolog of the Gli transcription factors)
(62,63). It was recently shown that Kif7-mutant neural progeni-
tors and cultured fibroblasts have abnormally long primary cilia
with structural defects at the ciliary axoneme (21). Our data are
consistent with the notion that Kif7 over-expression leads to
shorter cilia and decreased Shh signaling.
The overall reduction and marked disorganization of Ptch
and Smo subcellular localization which we have shown in
Npc1-deficient mice by transmission electron microscopy fur-
ther supports the presence of defective Shh signal reception in
our murine model of NPC1 disease. Particularly intriguing is the
presence of Ptch and Smo immunopositive vesicles recycling
from the plasma membrane and clustered in mvbs (degradation
sites) in PCs of Npc1/ mice; this indicates a severe impairment
of autocrine Shh signaling in these cells and may explain their
selective vulnerability to Npc1-deficiency.
The overall disorganization of Shh signaling, along with the
shortening of primary cilia, raises the possibility of considering
NPC1 disease a ciliopathy. In fact, recent studies have linked de-
fects of genes encoding for ciliary proteins to various cerebellar
disorders (64), laying the basis for a coherent definition and
classification of human ciliopathies. These are genetic diseases
initially grouped by clinicians on the basis of most striking clin-
ical features (Bardet Biedl syndrome for its polydactyly, obesity
and retinitis pigmentosa, now known to be the result of muta-
tions of 10 different ciliary genes; and Joubert syndrome for its
cerebellar dysplasia but now known to be sometimes associated
with diverse features, including those of Bardet-Biedl syndrome,
with 15 ciliary protein genes, possibly mutated). The relative
severity of the cilia defects can vary from place to place, even
within different brain areas (65), likely explaining the different,
but partially overlapping, clinical features among ciliopathies.
Post-mortem findings in the brain of Joubert syndrome were
described as total aplasia of the cerebellar vermis with dysplasia
and numerous heterotopias of cerebellar nuclei (66). Such cere-
bellar dysplasia, along with retinal abnormalities (67) and anos-
mia, (68) are shared between Niemann-Pick C1 mutants and
other ciliopathies. Thus, a good case can be made for classifying
the pre-inflammation and neurodegenerative stages of
Niemann-Pick C1 as a ciliopathy.
A putative candidate for altered ciliogenesis in NPC1 disease
is altered autophagy, although the role of autophagy in NPC1 dis-
ease has so far been controversial. Pacheco et al. (69) observed
increased levels of basal autophagy as indicated by elevated
amounts of LC3-II in NPC1 deficient mouse and human fibro-
blasts cultured in the presence of non-delipidated serum.
However, when autophagic flux was measured, instead of just
monitoring amounts of LC3-II, impaired degradation and accu-
mulation of autophagosomes was observed (70). These results ob-
tained with cultured fibroblasts were also extended to NPC1
cultured neurons and the autophagic defect was shown to lead to
decreased viability of the mutant neurons (71). Such a defect
could be caused by the altered ciliogenesis we detected; alterna-
tively, the shortened cilia could be influenced by the altered
autophagy, due to primary cilium formation and autophagy being
two mutually regulated processes during serum starvation (72).
However, these authors also studied the balance between the
two processes by blocking the intracellular flagellar transport,
suggesting that limitations of these ciliary components by
autophagy limits ciliary growth; this suggests that autophagy
may be primary. However, it is worth noting that the shortened
cilia we have detected in human mutant fibroblasts were found
while the cells were well supplied with cholesterol and protein,
namely conditions that certainly do not increase autophagy.
The findings of this study are significant because they: (i)
correlate the defective Shh signaling to the mild hypoplasia of
the cerebellum and; (ii) show for the first time that the forma-
tion of the primary cilium is altered in NPC1 disease.
Materials and Methods
Animals and treatments
Npc1/ mice with BALB/cJ background obtained from heterozy-
gous crosses were exposed to a 12-h light–dark cycle, receiving
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food and water ad libitum. Pup genotypes were identified by PCR
analysis of tail DNA as described (73). Treatment with CD
(Sigma-Aldrich, Milan, Italy) was performed by two subsequent
subcutaneous injections of either a 20% solution (w/v; 4000 mg/
kg body weight) of CD in phosphate buffered saline (PBS) or
plain PBS, for controls, to 4- and 7-day-old mice Npc1/ and
wild-type (wt) littermates (12,74). Experimental protocols and
related procedures were approved by the Italian Ministry of
Public Health. All efforts were made to minimize animal suffer-
ing, according to European Directive 2010/63/EU.
Cell culture and treatments
Human fibroblasts were obtained from skin biopsies from seven
patients affected by NPC1 disease, and six healthy controls. All
NPC1 disease patients presented the classical biochemical
phenotype characterized by massive LE/LY accumulation of
unesterified cholesterol in cultured fibroblasts, and diagnosis
was confirmed by sequencing both NPC1 and NPC2 genes. All
patients presented mutations in the NPC1 gene (Table 1, RefSeq
cDNA NM_000271.4). Written consent was obtained from all
subjects involved in the study.
Fibroblasts were cultured and maintained in Dulbecco’s
modified Eagle’s medium (Gibco, Paisley, UK) supplemented
with 10% fetal calf serum and 50 mg/ml penicillin/streptomycin,
in a humidified atmosphere containing 5% CO2 at 37 C. To
induce primary cilium formation, cells were cultured in
a serum-free medium for 24 h in the absence or presence of CD
(final concentration of 400 or 800 lM).
Immuno-electron microscopy
PN18 and adult Npc1/ and wt mice were deeply anesthetized
by an intraperitoneal injection of a mixture of xylazine (20 mg/
kg) and ketamine (34 mg/kg) and then transcardially perfused
with freshly depolymerized 4% paraformaldehyde (PFA) and
0.05% glutaraldehyde in a 0.1 M phosphate buffer (PB). Cerebella
were dissected out, post-fixed in the same fixative overnight
(ON) at 4 C and cut into 50 lm thick sagittal sections using a
vibratome. Sections were first cryoprotected in 10% dimethyl
sulfoxide (DMSO) þ 1% glycerol (10 min at 4 C) and 20% DMSO þ
2% glycerol (2 10 min at 4 C), and then frozen-thawed four
times in liquid nitrogen-cooled isopentane, for tissue perme-
abilization. After a brief wash in PB, endogenous peroxidases
were blocked by incubation in 10% methanol and 3% H2O2 in 0.1
M PB (10 min at RT). Sections were rinsed again, incubated in a
blocking solution (1% bovine serum albumin, BSA, 10% normal
goat serum, NGS, in 0.1 M PB) for 1 h at RT and then in the
primary antibodies, rabbit anti-Ptch and rabbit anti-Smo,
diluted in 1% BSA, 1% NGS in 0.1 M PB (Table 2).
After a rinse in PB, sections were incubated with the appro-
priate secondary antibody (Table 2) for 1 h at RT. Antibody
binding sites were revealed for 10 min in 0.05% 3,30-diaminoben-
zidine and 0.1% H2O2 in 0.1 M PB. After a thorough wash in PB,
sections were post-fixed in 1% osmium tetroxide (1 h at 4 C),
rinsed in bi-distilled chilled water (1 h) and 50% ethyl alcohol
(5 min), en-block stained for 20 min in 1% uranyle acetate in 70%
ethyl alcohol, and dehydrated in a series of ascending ethyl al-
cohol and propylene oxide. After an ON incubation in a mixture
1:1 of propylene oxide: Epon epoxy resin (Fluka; Sigma-Aldrich),
and 4 h in Epon, samples were flat embedded and polymerized
for 3 days at 60 C. Ultra thin sections were cut both tangential
and orthogonal to the embedded vibratome sections, collected
on copper grids, counterstained with a 0.2% lead citrate aqueous
solution and viewed at a Philips EM208S electron microscope
connected to a Megaview III video camera. Acquired images
were adjusted for light and contrast with the Adobe Photoshop
CS6 software.
Light microscopy histology, immunohistochemistry and
immunofluorescence
Npc1þ/þ (wt) and Npc1/ mice of postnatal days 12 (PN12), 18
(PN18) and 45 (adult) (4 mice/genotype/age), treated or not with
CD, were anaesthetized, as described above, and then transcar-
dially perfused with freshly depolymerized 4% PFA in 0.1 M PBS.
Brains were then further fixed in 4% PFA ON at 4 C, cryopro-
tected with sucrose (30% in PBS), embedded in FSC22 Clear R
Frozen Section Compound (Leica Biosystems, Milan, Italy) and
serially sectioned (slice thickness 25 lm) using a Leica CM 1900
cryostat. Sagittal sections were placed in PBS, separated into in-
dividual wells of a 24-well plate. Free floating sections were
then permeabilized with 0.3% Triton X-100 in PBS supplemented
with 2% NGS and 10 mg/ml BSA (Sigma-Aldrich). All incubations
and washes were carried out in PBS. Sections were incubated
with antibodies against the ciliary marker Adenylate cyclase III
(ACIII) (Santa Cruz Biotechnologies; or ProteinTech Group,
Milan, Italy) (Table 2) ON at 4 C and processed for IHC or IF.
In IHC assays, staining was revealed by using the rabbit
Vectastain Elite ABC kit (Vector Laboratories Inc., Burlingame,
CA, USA) and peroxidase substrate Vector VIP (Vector
Laboratories Inc.), according to the manufacturer’s instructions.
IF assays were performed using free-floating brain sections and
cultured human fibroblasts. After the incubation with the pri-
mary antibody, brain sections were washed three times in PBS
and incubated with Alexa Fluor 488- or 555-conjugated second-
ary antibodies (Invitrogen, Milan, Italy) (Table 2) for 1 h at RT.
Table 1. Genotype of patients included in the study
Patient Allele 1 Allele 2
NPC1 c.2819C>T (p.S940L) c.2833G>A (p.D945N)
NPC2 c.3056A>G (p.Y1019C) c.3056A>G (p.Y1019C)
NPC3 c.710C>T (p.P237L) c.3304C>T (p.L1102F)
NPC4 c.3182 T >C (p.I1061T) c.3182 T >C (p.I1061T)
NPC5 c.3424T>C (p.M1142T); c.1943T>A (p.L648H) c. 298T>A (p.C100S)
NPC6 c.1421 C>T (p.P474L) c.1501G>T (p.D501Y)
NPC7 c.2291C>T (p.A764V) c.2819C>T (p.S940L)
All patients presented a classical biochemical phenotype characterized by massive lysosomal accumulation of unesterified cholesterol. The lysosomal accumulation of
unesterified cholesterol was demonstrated by filipin staining.
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Nuclei were stained with Hoechst 33258 (Sigma-Aldrich).
Sections were transferred on glass slides and mounted by using
the Vectashield Mountain Medium (Vector Laboratories).
Human fibroblasts, grown on glass cover slips, were fixed with
4% PFA, permeabilized with an ice-cold solution of methanol/
acetone (1:1) for 10 min at 20 C and blocked in 2% BSA in PBS.
Cells were then incubated ON at 4 C with the primary antibod-
ies directed against acetylated alpha-tubulin (Sigma-Aldrich)
and c-tubulin (Sigma-Aldrich) and thereafter with the appropri-
ate Alexa Fluor 555- or 488-labeled secondary antibodies (Life
Technologies, Invitrogen, Milan, Italy), for 1 h at 37 C. Cover
slips were mounted with the DAPI-containing VECTASHIELD
Mounting Medium (Vector Laboratories). Immunodetection spe-
cificity was assessed by omitting the primary antibody in IHC
and IF assays. A list of primary and secondary antibodies used
is provided in Table 2.
Measurements of primary cilia
Imaging and quantification of the fraction of ciliated cells and
cilium length was performed using a Leica TCS NT confocal
laser (Leica Microsystem) with a 40 and 100 immersion ob-
jective lens and 4 optical zoom, a Leica DMI 6000B microscope
connected to a Leica DFC350FX camera (Leica Microsystems)
and a Zeiss Axioplan microscope. Due to the differences in the z
resolution of the confocal microscope, compared with the x and
y planes, only cilia that were 90 to the incident light were se-
lected. Serial optical z-sections were collected for each image.
Two-dimensional projections of cilia were acquired from a min-
imum of 30 cells for each area (CA1 of hippocampus) and cilium
length was measured using the ‘z projection’ function of Image J
NIH software (NIH Image, Bethesda, MD). When the length of
cilia was determined by using optical microscopes, the cover
slips were pressed hard against microscope slides to flatten
most of the cilia. Only cilia that were flattened into one plane
were selected for image acquisition and cilium length measure-
ment (75). The distance from the base to the tip of the cilium
was measured by tracing the length of the cilium, using Image
J’s segmented line tool (rsb.info.nih.gov/ij). The fraction of cili-
ated cells in a given field was determined by counting the num-
ber of cilia and the number of nuclei and expressed as a % of
total cells. Cilia prevalence was measured in 10 fields (almost 25
cells/field) in three separate experiments, giving a total of 800
mouse cells and 100 human fibroblasts respectively per experi-
mental group.
RNA preparation and real-time RT-PCR
Total RNA was extracted from cerebella of PN7-PN12, wt and
Npc1/ mice, treated or not with CD, using the RNeasy Lipid
Tissue mini kit (Qiagen, Hilden, Germania). cDNA was synthe-
sized using the NZY First-Strand cDNA Synthesis kit (NZYtech,
Campus do Lumiar, Lisboa), following the protocol supplied by
the manufacturer. Real-time RT-PCR was performed by using
the KAPA SYBR qPCR kit (Kapa Biosystems, Boston, USA) with
the following cycling conditions: 95 C for 10 min, then 35 cycles
at 95 C for 10 s and 62 C for combined annealing/extension for
30 s. The QuantiFast PCR primers were: Mm_Ptch_SG (Cat No.
QT00149135), Mm_Gli1_SG (Cat No. QT00173537), Mm_Gli2_SG
(Cat No. QT00291711), Mm_Gli3_SG (Cat No. QT00102256) and
Mm_Rps16_SG (Cat No. QT0009256) (S16 ribosomal protein);
Mm_Smo_F: GCTGCCACTTCTATGACTTCT R: GCCGATTCTTGA
TCTCACAGT; Mm_Kif7_F: CTGGAGAAGGAACTAGGTCG R:TTT
CCAGGCAGAGGCTTCTC. Gene expression levels between ex-
perimental groups were analyzed using the 2DDCt method (76).
cDNA amounts were normalized to Rps16 and expressed as the
fold-increase over control. Expression levels were also normal-
ized to Gapdh (not shown).
Table 2. Antibodies used
Antibody Company Dilution
WBa IHC/IF/TEMb
Primary anti-c-tubulin Sigma Aldrich; no.T5192 1:2000 1:500
anti-c-tubulin Sigma Aldrich; no.T6557 1:10000 1:5000
anti-acetylated tubulin Sigma Aldrich; no.T6793 1:6000 1:1500
anti-ACIII (C-20) Santa Cruz; sc-588 1:200 1:100
anti-ACIII ProteinTech Group Inc; no.19492-1-AP 1:1000 1:50
anti-GAPDH Sigma Aldrich; no.G9545 1:10 000 —–
anti-patched AbCam; no.Ab53715 1:500 1:1000
anti-smoothened AbCam; no.Ab38686 1:250 1:500





Thermo Fisher Scientific; no.32460 1:200 —–
Horseradish peroxidase-conjugated
goat anti-mouse IgG
Thermo Fisher Scientific; no.32430 1:650 —–
Biotinylated goat anti-rabbit IgG Vector Laboratories, Burlingame; no.PK-6101 —– 1:200
Biotinylated goat anti-mouse IgG Vector Laboratories; no.PK-6102 —– 1:200
Goat anti rabbit IgG Covance; no.SMI-5030C 1:400
Activity-select PA anti-rabbit Covance; no.SMI-4010L —– 1:100
Alexa Fluor 488 conjugated goat anti-rabbit Thermo Fisher Scientific; no.A-11008 —– 1:500
Alexa Fluor 488 conjugated goat anti-mouse Thermo Fisher Scientific; no.A-21422 —– 1:500
aWB, western blot assay.
bIHC, immunohistochemistry; TEM, transmission electron microscopy.
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Western blot analysis
For western blot analyses, total protein from PN12, PN18 and
PN45 Npc1/ and wt littermate cerebella (four mice/genotype/
age) were extracted with RIPA buffer (Sigma-Aldrich) supple-
mented with protease and phosphatase inhibitors (Roche Life
Science Indianapolis, IN, USA), as previously described in (77).
Protein concentration was routinely determined by Bradford’s
colorimetric assay (Bio-Rad, Milan, IT). Equal amounts of total
protein/lane were fractionated by electrophoresis on a 4-12%
gradient SDS-polyacrylamide gel (Bolt Bis-Tris Plus gels, Life
Technologies) or 10% gel pre-cast (Bio-Rad). Fractionated pro-
teins were transferred to PVDF membranes (GE Healthcare,
Little Chalfont, UK) and, after blocking, membranes were incu-
bated ON at 4 C with the primary antibodies, washed, incu-
bated with the appropriate secondary antibody for 1 h at RT and
developed with the SuperSignal West Dura reagent (Thermo
Scientific/Pierce, Rockford, IL, USA). The primary and secondary
antibodies used are reported in Table 2. Immunopositive bands
were quantified by using a Gel Doc 2000 videodensitometer
(Biorad, Hercules, CA, USA).
Statistics
Statistical analyses were performed using the GraphPad Prism
version 5.0d (GraphPad, La Jolla, CA). Data is expressed as mean
values 6 SEM. Statistically significant differences were analyzed
by one- and two-way ANOVA and Tukey post hoc tests. P-values
<0.05 were considered significant. The unpaired student’s t-test
was used to evaluate differences between wt and Npc1/ at PN7.
Supplementary Material
Supplementary Material is available at HMG online.
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